Page last updated: 2024-08-17

medroxyprogesterone acetate and Precursor Cell Lymphoblastic Leukemia-Lymphoma

medroxyprogesterone acetate has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bavaro, P; Bellati, U; Bizzarri, M; Carabella, G; Iammarrone, E; Mattaeis, RD; Torlontano, G1

Other Studies

1 other study(ies) available for medroxyprogesterone acetate and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
[Efficacy of estrogen-progestin replacement therapy after bone marrow transplantation].
    Minerva ginecologica, 1996, Volume: 48, Issue:9

    Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; beta-Thalassemia; Bone Marrow Transplantation; Child; Child, Preschool; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Medroxyprogesterone Acetate; Multiple Myeloma; Neural Tube Defects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Myelofibrosis; Primary Ovarian Insufficiency; Progesterone Congeners; Prospective Studies

1996